Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.7210
+0.0009 (0.12%)
At close: May 19, 2026, 4:00 PM EDT
0.7130
-0.0080 (-1.11%)
After-hours: May 19, 2026, 4:04 PM EDT
Dyadic International Revenue
Dyadic International had revenue of $1.11M in the quarter ending March 31, 2026, with 182.28% growth. This brings the company's revenue in the last twelve months to $3.81M, up 7.13% year-over-year. In the year 2025, Dyadic International had annual revenue of $3.09M, down -11.59%.
Revenue (ttm)
$3.81M
Revenue Growth
+7.13%
P/S Ratio
6.90
Revenue / Employee
$634,622
Employees
6
Market Cap
26.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.09M | -405.04K | -11.59% |
| Dec 31, 2024 | 3.50M | 596.58K | 20.58% |
| Dec 31, 2023 | 2.90M | -31.49K | -1.07% |
| Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
| Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
| Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
| Dec 31, 2019 | 1.68M | 385.63K | 29.77% |
| Dec 31, 2018 | 1.30M | 537.03K | 70.81% |
| Dec 31, 2017 | 758.42K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Barinthus Biotherapeutics | 14.97M |
| Palatin Technologies | 12.88M |
| Kyntra Bio | 7.44M |
| Traws Pharma | 2.73M |
| ABVC BioPharma | 797.92K |
| Neuphoria Therapeutics | -13.27K |
DYAI News
- 13 hours ago - Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference - GlobeNewsWire
- 6 days ago - Dyadic International Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Dyadic International Earnings release: Q1 2026 - Filings
- 6 days ago - Dyadic International Quarterly report: Q1 2026 - Filings
- 6 days ago - Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 7 days ago - Dyadic International Proxy statement: Proxy filing - Filings
- 18 days ago - Dyadic International Slides - Filings
- 18 days ago - Dyadic International Proxy statement: Proxy filing - Filings